Vyas, Chintan <br/><br/>
Experience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity.  [electronic resource] 

 -  Pediatric hematology and oncology   
 - 331-340 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1521-0669 
<br/><br/><label>Standard No.: </label>10.1080/08880018.2018.1538277  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Asparaginase--administration & dosage<br/>Child<br/>Daunorubicin--administration & dosage<br/>Disease-Free Survival<br/>Drug Monitoring<br/>Drugs, Generic--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Polyethylene Glycols--administration & dosage<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Prednisone--administration & dosage<br/>Survival Rate<br/>Vincristine--administration & dosage